COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...
Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.
Video above: Will you get the COVID-19 vaccination?University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas, a key researcher said ...
Hosted on MSN
New 2025 data shows COVID-19 vaccines continue to provide effective, durable protection
Subscribe to our newsletter for the latest sci-tech news updates. Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were ...
COVID-19 and flu vaccination rates in Washington have fallen this season compared with the previous year, according to state data. Washington's Department of Health, to help address the problem, ...
(NewsNation) — The commissioner of the Food and Drug Administration says the agency will not overlook anything in developing new guidelines for COVID-19 vaccines. “A lot of people report vaccine ...
COVID-19 vaccine hesitancy in England decreased from 8.8% to 2.2%, yet mistrust-driven attitudes remained a strong barrier to uptake.
Walensky is a professor at Harvard Medical School and served as the 19th director of the Centers for Disease Control and Prevention. Once clinical trials showed that Covid-19 vaccines were safe and ...
(CNN) — In response to a call from President Donald Trump to make the positive impact of Covid-19 vaccines public, drug giant Pfizer posted a collection of more than 200 press releases and statements ...
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results